oral glp-1 drugs in development The Chase for Novel Obesity Meds Adds a New Contender The challenge of developing oral

This is associated with better focus and reduced neurotoxicity

Oral L-Carnitine has poor bioavailability (518% at high doses) due to saturable intestinal absorption [3]

The observed effect was attributed to DSePA-mediated suppression of DNA damage response pathways and, in turn, the inhibition of DNA repair in the irradiated lung cancer cells

Physiological application of methionine supplementation is dose-dependent, for instance, a low methionine diet suppresses the neurogenesis in animal models, whereas high dietary methionine has been associated with mild cognitive impairment primarily due to mitochondrial dysfunction (197)